FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/08/2026
Voltar para busca
Dado oficial do USPTO
S-OPTICHARGE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
23
Atualização mais recente
12/08/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 40, 42
Data de depósito
10/01/2025
Data de registro
12/05/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
12/05/2026
Última transação
12/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
03
Localização do titular
KR
Examinador
BLAZICH, JOAN MICHELE
Unidade examinadora
N40
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the stylized wording "S-OPTICHARGE".
Titulares e representantes
Titulares
Samsung Biologics Co., Ltd.
Representantes
Brian P. Gregg McNees Wallace & Nurick
Classificação técnica
Classes Nice
Classe 1Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Preparations being industrial chemicals for gene recombination for scientific or laboratory purposes; chemical reagents for genetic identity testing for non-medical purposes; chemical reagents for use in genetic research; chemical reagentsother than for medical or veterinary purposes; synthetic gene for research other than for medical purposeschemical reagents for use in genetic research; biological preparations for use in biotechnology being use in industry and science other than for medical purposes; chemicals for use in biotechnological product development; enzymes derived from biotechnological processes for use in industry; biological preparation for use in cell cultures other than for medical or veterinary use; biological tissue culturesother than for medical or veterinary purposes; reagents for scientific and research use for use in scientific apparatus for chemical or biological analysis; stem cells other than for medical or veterinary purposes; stem cells for research purposes; stem cells for scientific purposes; cell growth media for growing cells for use in scientific research; cells for scientific or research laboratory purposes
Classe 40
Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials; custom manufacture of cell lines for manufacturing biopharmaceuticals; chemical treatment of liquids; processing of medicinal materials; custom manufacture of pharmaceuticals; processing of pharmaceutical preparations; preservation of pharmaceuticals; processing of pharmaceuticals; custom manufacture of specific antibody-binding glycosylated drugs; processing of chemicals
Classe 42
Scientific laboratory services for high-efficiency glycan analysis; culturing of cells for others for scientific research purposes; scientific research; biological research and analysis relating to glycosylation profiles; multiple nucleic acid scientific analysis; scientific protein analysis; scientific toxicity analysis; analysis in the field of molecular biology; development of biotechnology; biotechnological research; biological analysis; biological research; research of biologics; biochemical analysis; biochemical research; food research; conducting early evaluations in the field of new pharmaceuticals; drug discovery services; development of pharmaceutical preparations and medicines; pharmaceutical research and development; research on the subject of pharmaceuticals; pharmaceutical product evaluation; clinical research in the field of medicine; scientific analysis services for assessing the efficiency of pharmaceuticals; scientific research in the field of genetics and genetic engineering; animal genetic research; computer programming in the medical field; medical research laboratories; computer software technical support services relating to the management of medical image datatroubleshooting of computer software problems; medicine research; scientific analysis and evaluation of medical product development; providing scientific information on the testinginspection and research of medical products; evaluating of clinical trial progressquality control for others; conducting clinical trials for others
Publicações
Histórico de despachos e eventos da marca no USPTO.
23 publicações encontradas
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/08/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/08/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/05/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
12/05/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/03/2026
PUBO
PUBLISHED FOR OPPOSITION
24/03/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18/03/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
27/02/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/02/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/02/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/02/2026
PETG
PETITION TO REVIVE-GRANTED
23/02/2026
PROA
TEAS PETITION TO REVIVE RECEIVED
23/02/2026
RFNT
REFUSAL PROCESSED BY IB
29/08/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
14/08/2025
RFRR
REFUSAL PROCESSED BY MPU
13/08/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/07/2025
CNRT
NON-FINAL ACTION WRITTEN
01/07/2025
DOCK
ASSIGNED TO EXAMINER
18/06/2025
MAFR
APPLICATION FILING RECEIPT MAILED
09/03/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/03/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/03/2025
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace S-OPTICHARGE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.